Sei Investments Co. Acquires 40,425 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Sei Investments Co. raised its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 9.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 472,169 shares of the company’s stock after purchasing an additional 40,425 shares during the period. Sei Investments Co.’s holdings in Henry Schein were worth $32,674,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. Smartleaf Asset Management LLC grew its stake in shares of Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after buying an additional 143 shares during the last quarter. CIBC Asset Management Inc grew its stake in shares of Henry Schein by 1.0% in the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock worth $1,235,000 after acquiring an additional 169 shares during the last quarter. Metis Global Partners LLC increased its holdings in shares of Henry Schein by 4.7% during the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock valued at $291,000 after acquiring an additional 187 shares in the last quarter. Central Pacific Bank Trust Division raised its position in shares of Henry Schein by 2.0% in the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock worth $706,000 after purchasing an additional 200 shares during the last quarter. Finally, Sanctuary Advisors LLC boosted its stake in Henry Schein by 5.0% in the 4th quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company’s stock worth $294,000 after purchasing an additional 203 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Price Performance

NASDAQ HSIC opened at $69.38 on Wednesday. The company has a 50-day moving average price of $74.79 and a 200-day moving average price of $72.65. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $8.62 billion, a P/E ratio of 28.55, a PEG ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion for the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.66 earnings per share. Equities research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have weighed in on HSIC shares. UBS Group reduced their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Mizuho initiated coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target for the company. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a research report on Wednesday, February 26th. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Jefferies Financial Group upped their price target on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $81.10.

Insider Buying and Selling

In related news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.